Recombinant pox virus for immunization against tumor-associated antigens
US6699475B1 · kind B1 · utility
15Cited by
4References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 7, 1995 |
| Grant date | Mar 2, 2004 |
| Priority date | — |
| Expiry date | Jun 7, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/24143
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Recombinant pox viruses capable of expressing cell-encoded, tumor-associated antigens are disclosed. The recombinant viruses are useful for evoking an immune response against the antigen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.